J. Scott Wolchko
2019
In 2019, J. Scott Wolchko earned a total compensation of $10.7M as President, Chief Executive Officer and Director at Fate Therapeutics, a 204% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $310,500 |
|---|---|
| Option Awards | $5,732,955 |
| Salary | $540,000 |
| Stock Awards | $4,137,500 |
| Total | $10,720,955 |
Wolchko received $5.7M in option awards, accounting for 53% of the total pay in 2019.
Wolchko also received $310.5K in non-equity incentive plan, $540K in salary and $4.1M in stock awards.
Rankings
In 2019, J. Scott Wolchko's compensation ranked 658th out of 13,971 executives tracked by ExecPay. In other words, Wolchko earned more than 95.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 658 out of 13,971 | 95th |
Division Manufacturing | 231 out of 5,701 | 96th |
Major group Chemicals And Allied Products | 62 out of 2,200 | 97th |
Industry group Drugs | 52 out of 1,886 | 97th |
Industry Biological Products, Except Diagnostic Substances | 10 out of 389 | 97th |
Source: SEC filing on April 21, 2021.
Wolchko's colleagues
We found three more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2019.